Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
239
NCT01313962
Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2011
Completion: Jan 31, 2012
NCT01585532
Alere Mycobacterium Tuberculosis Urine Study
Phase: N/A
Role: Collaborator
Start: Jan 31, 2012
Completion: Dec 31, 2013
NCT01990846
Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
Start: Mar 31, 2014
Completion: Feb 28, 2015
NCT02423577
Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
Phase: Phase 2
Start: Sep 30, 2015
Completion: Jun 30, 2016